Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is harnessing the science of epigenetics to uncover hidden risks of heart disease that traditional genetic testing may miss. The company's diagnostic platform focuses on how lifestyle, behavior, and environment influence gene expression, providing a more comprehensive view of cardiovascular health.
Epigenetics examines changes in gene activity that do not involve alterations to the underlying DNA sequence. This field can reveal how factors such as diet, stress, and pollution turn genes on or off, potentially increasing or decreasing disease risk. Cardio Diagnostics' approach goes beyond identifying problems; CEO Meesha Dogan emphasizes that it also offers solutions by suggesting actionable steps to mitigate risk.
While family history and genetics are important, research indicates they account for only a portion of cardiovascular risk. Epigenetics fills this gap by capturing the dynamic interplay between genes and environment. For example, two individuals with identical genetic predispositions may have vastly different risks based on their epigenetic profiles.
The company's tests analyze epigenetic markers from a simple blood sample, providing insights into conditions like coronary artery disease, heart attack risk, and other cardiovascular issues. This information can guide personalized prevention and treatment strategies.
Cardio Diagnostics has positioned itself at the forefront of precision medicine in cardiology. Its technology is designed to be accessible and scalable, with potential to transform how heart disease is predicted and managed. The company continues to conduct research and collaborate with healthcare providers to validate and expand its offerings.
For more information, visit the company's newsroom at https://ibn.fm/CDIO.
This development underscores a broader shift in medicine toward understanding not just our genetic blueprint but how it is expressed in real-world conditions. As epigenetics gains traction, it promises to unlock new avenues for early detection and personalized care in cardiovascular health.
